PrEP may be prescribed and started the same day
There are different PrEP options to help fit each individual’s needs
Discuss PrEP today
(Tao L, 2023; 522,273 prescriptions of PrEP were analyzed between January 2019 and February 2023, selected from IQVIA® LAAD. Observational study compared delays of PrEP dispensation from day 0, when PrEP was dispensed.2)
IQVIA LAAD=IMS Health, Quintiles, and VIA Longitudinal Access and Adjudication Data.
Three steps to prescribe PrEP:
Screen for HIV1
A negative HIV test is required. Some PrEP options also require HBV screening and confirmation of CrCl levels.
Counsel individuals3
How to take their PrEP medication for HIV prevention and safer sex practices to prevent STIs.
Regularly screen for STIs3
Some PrEP options also require continued renal function monitoring.
Talk about PrEP as soon as possible with the individuals in your practice who may need or want it.
CrCl=creatinine clearance; HBV=hepatitis B virus; STI=sexually transmitted infection.
CrCl=creatinine clearance; HBV=hepatitis B virus; STI=sexually transmitted infection.
Learn about an FDA-approved HIV prevention option that may be appropriate for some people you see in your practice.
Resources available to help individuals access PrEP
A wide variety of efforts are focused on supporting access to PrEP medications and associated visits
- Manufacturer access programs for individuals with or without insurance4
- The Affordable Care Act (ACA) requires almost all plans to cover PrEP medications and associated visits with no cost sharing1,5
- Government organizations
- Medicare, Medicaid, and the US Department of Veterans Affairs5,6
- State- and city-based programs1,6
- Patient advocacy organizations6
References:
1. Centers for Disease Control and Prevention. HIV Nexus: CDC resources for clinicians. Updated August 20, 2024. Accessed September 4, 2024. https://www.cdc.gov/hivnexus/hcp/prep/index.html
2. Tao L, Yang J, Zachry W, Gruber J, Mezzio D. The real-world impact of pre-exposure prophylaxis (PrEP) prescription uptake and dispensing status on HIV infection risk in the US. Poster presented at: IDWeek 2023; October 11-15, 2023; Boston, MA. Poster 1557.
3. Centers for Disease Control and Prevention. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 Update: a clinical practice guideline. Accessed September 12, 2024. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
4. Data on file. Gilead Sciences, Inc.
5. Nicoletti B; HIV Medicine Association. Billing Coding Guide for HIV Prevention. National Alliance of State and Territorial AIDS Directors (NASTAD). Published April 2016. Accessed September 12, 2024. https://nastad.org/sites/default/files/2021-12/PDF_BillingCodingGuide_v5.pdf
6. Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014. Centers for Disease Control and Prevention. Published December 11, 2014. Accessed September 15, 2024. https://stacks.cdc.gov/view/cdc/44064